BrainStorm Cell Therapeutics GAAP EPS of -$0.35
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
SEBI Chief Tuhin Kanta Pandey Says Closing Auction Session Is Here to Stay, Tweaks Possible
SEBI Chairman Tuhin Kanta Pandey on August 17 said the market regulator is examining concerns surrounding the newly introduced Closing Auction Session (CAS), while making it clear that the mechanism…
Chinese Steel Output Tumbles as Economic Conditions Worsen
Chinese steel production tumbled last month, putting the industry on track for the lowest annual total this decade as mills adjust to much weaker demand.
Egypt’s US$8bn IMF Programme Ends 15 December
The IMF board cleared Egypt's seventh review on 30 July, releasing about US$1.8bn. The arrangement itself expires on 15 December 2026.
